JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 1989; 68:208-213
© 1989 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wierda, J. M. K.H.
Right arrow Articles by Agoston, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wierda, J. M. K.H.
Right arrow Articles by Agoston, S.

Dose-Response Relation and Time Course of Action of Pipecuronium Bromide in Humans Anesthetized with Nitrous Oxide and Isoflurane, Halothane, or Droperidol and Fentanyl

J. Mark K.H. Wierda, MD, F. John Richardson, MD, FFARCS, and Sandor Agoston, MD, PhD

Research Group of the Institutes for Experimental Anesthesiology and Clinical Pharmacology, University of Groningen, The Netherlands.

Abstract

The dose-response relation of pipecuronium bromide, the time course of its neuromuscular blocking effects, and the reversibility of the residual block by neostigmine and edrophonium have been investigated in patients undergoing various types of anesthesia. The estimated doses of pipecuronium required for 95% depression of the twitch height were 44.6, 46.9, and 48.7 figkg–1 during anesthesia with nitrous oxide (65%) and isoflurane (group 1), halothane (group 2), or droperidol/fentanyl (group 3), respectively.

The potentiating effects of the volatile anesthetics were reflected by the significant prolongation of the duration of both initial (50.0 ± 4.3, 36.0 ± 3.3, and 29.0 ± 2.0 minutes) and maintenance doses (56.0 ± 2.5, 49.5 ± 3.3, and 41.2 ± 1.6 minutes) of pipecuronium during anesthesia with nitrous oxide and isoflurane, halothane, or droperidol! fentanyl, respectively. Both edrophonium chloride (0.5 mg-kg–1) and neostigmine methylsulphate (40 Hgkg–1) promptly reversed the residual block induced by pipecuronium. No side effects attributable to pipecuronium were seen in this study.

Key Words: ANESTHETICS, INTRAVENOUS—fentanyl, droperidol • ANESTHETICS, VOLATILE—halothane, isoflurane • NEUROMUSCULAR RELAXANTS, PIPECURONIUM




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
G. van Santen, J. M. K. H. Wierda;, P. S. Clifford, Z. Valic, J. S. Naik, and J. B. Buckwalter;
Effect of Vecuronium on the Release of Acetylcholine After Nerve Stimulation
J Appl Physiol, September 1, 2000; 89(3): 1250 - 1250.
[Full Text]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
J. D. Swenson and P. L. Bailey
Opioids in Cardiovascular Anesthesia
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1997; 1(2): 146 - 163.
[PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 1989 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1989 by the International Anesthesia Research Society.